Funding for this research was provided by:
Wellcome Trust
Article History
Received: 21 April 2021
Accepted: 22 June 2021
First Online: 30 June 2021
Declarations
:
: Not applicable.
: Not applicable.
: GG and KM have no competing interests to declare. MFM has undertaken advisory board work and received speaker fees from Novartis and undertaken advisory board work for Celgene, Incyte and AbbVie.